Australian Business Review article of EBR Systems progress in 2024
EBR Systems pioneered the WiSE Cardiac Resynchronization Therapy (CRT) system tech, the size of a grain of rice.
Shares in an ASX-listed medical technology firm backed by investors including Bill Ferris and Mark Carnegie have surged 10.5 per cent on Monday after it revealed positive clinical trial results, which clear the way for US Food and Drug Administration approval for its tiny cardiovascular device.
EBR Systems makes a tiny gadget that sits inside the heart to help it pump enough blood, and is working towards regulatory approval in Australia and the US.
Jeffrey Alison and a device the size of a small grain of rice have transformed Ms Neu's life.
Keeping pace with technology, NCH is launching a research institute to test and deliver the latest medical advances. One of which is a new, and small, heart pacemaker.
Excellent interim analysis results lead to early trial success and are a major company milestone, significantly de-risks EBR Systems.
